MEDILIM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDILIM
Largest movements
- Current investments +€200,000
up €200,000 (+200.0%), from €100,000 to €300,000
- Cash -€130,112
down €130,112 (-39.1%), from €332,730 to €202,618
mainly Current investments (-€200,000) and Tax, wage and social debts (-€10,285)
- Intangible fixed assets -€19,387
down €19,387 (-44.5%), from €43,595 to €24,208
- Receivables within one year -€13,786
down €13,786 (-16.5%), from €83,719 to €69,933
of which Trade receivables: -€14,027
- Profit (loss) carried forward +€112,644
up €112,644 (+46.3%), from €243,286 to €355,929
- Reserves -€60,000
down €60,000 (-100.0%), from €60,000 to €0
- Tax, wage and social debts -€10,285
down €10,285 (-28.9%), from €35,558 to €25,274
of which Remuneration and social security: -€21,594
- Provisions -€10,000
down €10,000 (-100.0%), from €10,000 to €0
- Gross operating margin -€13,612
down €13,612 (-6.3%), from €216,808 to €203,195
- Staff costs -€7,892
down €7,892 (-6.9%), from €114,159 to €106,267
- Depreciation +€6,662
up €6,662 (+45.7%), from €14,567 to €21,229
- Financial income -€2,672
down €2,672 (-32.2%), from €8,306 to €5,634
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €560,044 | €596,759 | +€36,715 | +6.6% |
| Fixed assets | 21/28 | €43,595 | €24,208 | -€19,387 | -44.5% |
| Intangible fixed assets | 21 | €43,595 | €24,208 | -€19,387 | -44.5% |
| Tangible fixed assets | 22/27 | €0 | - | = | |
| Assets under construction and advance payments | 27 | €0 | - | = | |
| Current assets | 29/58 | €516,449 | €572,551 | +€56,102 | +10.9% |
| Amounts receivable within one year | 40/41 | €83,719 | €69,933 | -€13,786 | -16.5% |
| Trade receivables | 40 | €83,682 | €69,655 | -€14,027 | -16.8% |
| Other amounts receivable | 41 | €38 | €279 | +€241 | +640.9% |
| Current investments | 50/53 | €100,000 | €300,000 | +€200,000 | +200.0% |
| Cash at bank and in hand | 54/58 | €332,730 | €202,618 | -€130,112 | -39.1% |
| Total equity and liabilities | 10/49 | €560,044 | €596,759 | +€36,715 | +6.6% |
| Equity | 10/15 | €478,155 | €530,799 | +€52,644 | +11.0% |
| Contributions | 10/11 | €174,870 | €174,870 | = | 0.0% |
| Capital | 10 | €174,870 | €174,870 | = | 0.0% |
| Reserves | 13 | €60,000 | €0 | -€60,000 | -100.0% |
| Profit (loss) carried forward | 14 | €243,286 | €355,929 | +€112,644 | +46.3% |
| Provisions and deferred taxes | 16 | €10,000 | €0 | -€10,000 | -100.0% |
| Provisions for liabilities and charges | 160/5 | €10,000 | €0 | -€10,000 | -100.0% |
| Other liabilities and charges | 164/5 | €10,000 | €0 | -€10,000 | -100.0% |
| Amounts payable | 17/49 | €71,889 | €65,960 | -€5,929 | -8.2% |
| Amounts payable within one year | 42/48 | €69,253 | €64,810 | -€4,443 | -6.4% |
| Trade debts | 44 | €33,695 | €39,536 | +€5,841 | +17.3% |
| Suppliers | 440/4 | €33,695 | €39,536 | +€5,841 | +17.3% |
| Taxes, remuneration and social security | 45 | €35,558 | €25,274 | -€10,285 | -28.9% |
| Taxes | 450/3 | €13,964 | €25,274 | +€11,309 | +81.0% |
| Remuneration and social security | 454/9 | €21,594 | €0 | -€21,594 | -100.0% |
| Accrued charges and deferred income | 492/3 | €2,636 | €1,150 | -€1,486 | -56.4% |
| Remuneration, social security and pensions | 62 | €114,159 | €106,267 | -€7,892 | -6.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,567 | €21,229 | +€6,662 | +45.7% |
| Other operating charges | 640/8 | €37,595 | €38,540 | +€945 | +2.5% |
| Gross operating margin | 9900 | €216,808 | €203,195 | -€13,612 | -6.3% |
| Operating profit (loss) | 9901 | €65,486 | €47,159 | -€18,328 | -28.0% |
| Financial income | 75/76B | €8,306 | €5,634 | -€2,672 | -32.2% |
| Recurring financial income | 75 | €8,306 | €5,634 | -€2,672 | -32.2% |
| Financial charges | 65/66B | €55 | €149 | +€94 | +171.6% |
| Recurring financial charges | 65 | €55 | €149 | +€94 | +171.6% |
| Profit (loss) for the period before taxes | 9903 | €73,738 | €52,644 | -€21,094 | -28.6% |
| Profit (loss) for the period | 9904 | €73,738 | €52,644 | -€21,094 | -28.6% |
| Profit (loss) for the period to be appropriated | 9905 | €73,738 | €52,644 | -€21,094 | -28.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.